MedTrace Logo

Hemodynamics During Induction of General Anesthesia With Medium or Low Remifentanil Doses.

NCT03861377 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 99

Last updated 2022-03-21

No results posted yet for this study

Summary

In this trial the investigators want to examine if there is any difference in hemodynamic stability during induction when comparing two low and a medium remifentanil dose and keeping propofol induction dose at about 2.0 mg/kg.

Conditions

  • Hemodynamic Instability
  • Anesthesia, General
  • Anesthesia, Intravenous

Interventions

DRUG

Remifentanil R2

0,7 microg/kg

DRUG

Remifentanil R4

1,1 microg/kg

DRUG

Remifentanil R8

1,7 microg/kg

Sponsors & Collaborators

  • Helse Fonna

    lead OTHER

Principal Investigators

  • Gunnar Sjøen, MD · Helse Fonna

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-09
Primary Completion
2022-02-02
Completion
2022-02-02

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03861377 on ClinicalTrials.gov